Nucletron

Nucletron is a medical technology company specializing in brachytherapy solutions for cancer treatment, offering advanced systems that enhance radiation therapy precision and effectiveness. Founded in 1975 in the Netherlands, Nucletron focuses on developing innovative brachytherapy products. The company was acquired by Elekta AB in a deal worth EUR 365 million, finalized in September 2011. The current CEO is Jos Lamers, with Valerie van Graafeiland as part of the leadership team.

Nucletron provides advanced medical technology solutions in brachytherapy, including Elekta Studio for image-guided workflows, ImagingRing, Oncentra Brachy, and Flexitron. These products enable targeted radiation delivery while minimizing damage to healthy tissues, catering to hospitals and oncology clinics globally. Nucletron generates revenue through the sale of its brachytherapy products and associated services, including hardware and software solutions for cancer treatment. Their model includes direct sales to healthcare providers and may involve subscription services for ongoing support, with key products driving the revenue stream.

Following the acquisition by Elekta AB, Nucletron aims to enhance its product offerings and expand into new markets. The company plans to leverage the resources from the EUR 365 million funding to develop new products and enhance existing ones. Specific geographic expansion plans target growth in North America, Europe, and Asia, further solidifying their presence in these key regions.